EMEA-001150-PIP03-22 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: P/0015/2023
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Concentrate for solution for injection
Powder for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001266-PIP04-19 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Neurology
PIP number: P/0001/2020
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Alsitek
masitinib
Amyotrophic Lateral Sclerosis
Date of refusal:
Last updated:
MedicineHumanRefused
Masipro
masitinib
Mastocytosis
Date of refusal:
Last updated:
MedicineHumanRefused
EMEA-001266-PIP02-14 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Other
PIP number: P/0093/2015
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Masivet
masitinib mesilate
Dogs
Date of authorisation:
Revision: 6
Last updated:
MedicineVeterinaryAuthorised
EMEA-001266-PIP01-12 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0104/2012
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman